Money Concepts Capital Corp Sells 197 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Money Concepts Capital Corp cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,033 shares of the medical equipment provider’s stock after selling 197 shares during the period. Money Concepts Capital Corp’s holdings in Intuitive Surgical were worth $1,583,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new position in shares of Intuitive Surgical in the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter valued at about $36,000. Finally, Capital Performance Advisors LLP purchased a new stake in Intuitive Surgical during the third quarter worth about $38,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of research reports. Barclays increased their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Bernstein Bank increased their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a report on Monday, January 27th. Citigroup boosted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. Leerink Partners increased their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,967,734. The trade was a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 28,843 shares of company stock valued at $15,357,560 in the last 90 days. Corporate insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $590.90 on Thursday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a fifty day moving average of $551.99 and a 200 day moving average of $512.04. The firm has a market capitalization of $210.47 billion, a price-to-earnings ratio of 92.18, a P/E/G ratio of 5.51 and a beta of 1.39.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.